'Workshop on nanotechnology in diagnostic, monitoring and treatment of cancer advanced in molecular imaging', Dublin, Ireland
5 September 2012 - 5 September 2012
Ireland
The 'Workshop on nanotechnology in diagnostic, monitoring and treatment of cancer advanced in molecular imaging' will take place on 5 September 2012 in Dublin, Ireland.
Although the clinical arsenal in treating cancer has been greatly extended in recent years, the three basic approaches continue to be (in order of success) surgical resection, radiation, and chemotherapy. Conventional chemotherapeutic drugs are distributed non-specifically in the body where they affect both cancerous and healthy cells, resulting in dose-related side effects and inadequate drug concentrations reaching the tumour. To overcome the lack of specificity, nanotechnology provides and raises exciting opportunities for specific drug delivery.
Nanotechnology is being applied to cancer in two broad areas: the development of nanovectors, which can be loaded with drugs or imaging agents, and high-throughput nanosensor devices for detecting the biological signatures of cancer. Combined, such technologies could lead to earlier diagnosis and better treatment for patients with cancer.
The conference will provide a forum for scientists from academic, clinical and research institutions and industrial stakeholders to discuss and exchange information on the implementation of nanotechnologies into clinical molecular imaging practise. It will be held with the participation of the EU-funded 'Nanotechnolohical toolkits for multi-modal disease diagnostics and treament monitoring' (Namdiatream) project.For further information, please visit: http://www.wmicmeeting.org/nanotechnology-in-diagnostic-workshop/(opens in new window)
Although the clinical arsenal in treating cancer has been greatly extended in recent years, the three basic approaches continue to be (in order of success) surgical resection, radiation, and chemotherapy. Conventional chemotherapeutic drugs are distributed non-specifically in the body where they affect both cancerous and healthy cells, resulting in dose-related side effects and inadequate drug concentrations reaching the tumour. To overcome the lack of specificity, nanotechnology provides and raises exciting opportunities for specific drug delivery.
Nanotechnology is being applied to cancer in two broad areas: the development of nanovectors, which can be loaded with drugs or imaging agents, and high-throughput nanosensor devices for detecting the biological signatures of cancer. Combined, such technologies could lead to earlier diagnosis and better treatment for patients with cancer.
The conference will provide a forum for scientists from academic, clinical and research institutions and industrial stakeholders to discuss and exchange information on the implementation of nanotechnologies into clinical molecular imaging practise. It will be held with the participation of the EU-funded 'Nanotechnolohical toolkits for multi-modal disease diagnostics and treament monitoring' (Namdiatream) project.For further information, please visit: http://www.wmicmeeting.org/nanotechnology-in-diagnostic-workshop/(opens in new window)